Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Polymerase Chain Reaction (PCR) Market, 2022

This image opens in the lightbox

News provided by

Research and Markets

03 Nov, 2017, 11:15 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, November 3, 2017 /PRNewswire/ --

The "Polymerase Chain Reaction (PCR) - A Global Market Overview" report has been added to Research and Markets' offering.

Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.

North America leads the global market for PCR, estimated at US$3.5 billion (40.3% share) in 2017, which is expected to maintain a 2017-2022 CAGR of 7.5% in reaching a projected US$5 billion by 2022.

Asia-Pacific is expected to witness the fastest similar period robust CAGR of 9.2% and reach US$2.5 billion by 2022. Global demand for PCR in Clinical Diagnostics Labs & Hospitals, among end use sectors, is slated to record the fastest CAGR of 8.6% during the aforementioned analysis period.

Research Findings & Coverage

  • Global PCR market is examined in this report with respect to latest prominent technologies, major application areas and key end-use sectors
  • The report exclusively analyzes each application area, technology and end-use sector of PCR by a major geographic region
  • Droplet Digital PCR Surpasses Real-Time PCR in Detecting Environmental DNA
  • PCR Testing for Veterinary Diseases Gaining Momentum
  • Capillary Loop Convective Polymerase Chain Reaction Platform with Real-Time Fluorescence Detection Improves Amplification Efficiency
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 33
  • The industry guide includes the contact details for 161 companies

Product Outline

The report analyzes the market for the key product segments of PCR including:

  • Instruments
  • Reagents & Consumables
  • Software & Services

Application Areas of PCR analyzed comprise the following:

  • Clinical Diagnostics
  • Life Sciences
  • Others

End-Use Sectors of PCR analyzed comprise the following:

  • Academic & Research Institutes
  • Clinical Diagnostics Labs & Hospitals
  • Pharmaceutical & Biotechnology
  • Others

Analysis Period, Units and Growth Rates

  • The report reviews, analyzes and projects the global PCR market for the period 2014-2022 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2017 through 2022

Key Topics Covered:

Part A: Global Market Perspective

1. Introduction
1.1 Product Outline
1.1.1 What is Polymerase Chain Reaction (PCR)?
1.1.1.1 Procedure of PCR
1.1.1.2 The Exponential Cycle of PCR
1.1.1.3 Design of Primers
1.1.1.4 Components Required for PCR
1.1.1.5 Scrutiny of Fragment Identity
1.1.2 PCR Techniques
1.1.2.1 Digital PCR (dPCR)
1.1.2.2 Real-Time PCR
1.1.2.3 Other PCR Techniques
1.1.3 Applications of PCR

2. Key Market Trends
2.1 Expediting the PCR Process Now Possible
2.2 Emergence of Ultrafast Real Time Q-Plasmonic PCR
2.3 Contemporary Research Using BNA-Based Digital PCR
2.4 Detection of Early-Stage Liver Cancer Improves by Using CTC-iChip with Digital PCR Assay
2.5 Propidium Monoazide-PCR Assay Developed for Detecting viable Lactobacillus brevis in Beer
2.6 PCR Testing for Veterinary Diseases Gaining Momentum
2.7 RT-qPCR Improves Detection of Mycobacterium tuberculosis
2.8 Capillary Loop Convective Polymerase Chain Reaction Platform with Real-Time Fluorescence Detection Improves Amplification Efficiency
2.9 Droplet Digital PCR Surpasses Real-Time PCR in Detecting Environmental DNA
2.10 Nanoparticle-Assisted PCR Overcomes Technical Challenges
2.11 Litmus Test Used for Detecting DNA Amplicons of PCR
2.12 dPCR Used for Characterizing DNA Reference Materials
2.13 Innovative PCR Technique Improves Sequencing of Minute cfDNA

3. Key Global Players

  • Abbott Laboratories (United States)
  • Agilent Technologies, Inc. (United States)
  • Becton, Dickinson and Company (United States)
  • Biocartis NV (Belgium)
  • Bio-Rad Laboratories, Inc. (United States)
  • Danaher Corporation (United States)
  • Eppendorf AG (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Fluidigm Corporation (United States)
  • GE Healthcare Life Sciences (United Kingdom)
  • Merck KGaA (Germany)
  • Ocimum Biosolutions Ltd. (India)
  • Qiagen N.V. (The Netherlands)
  • Thermo Fisher Scientific, Inc. (United States)

4. Key Business Trends

5. Global Market Overview

5.1 Global Polymerase Chain Reaction Market Overview by Product Segment
5.1.1 Polymerase Chain Reaction Product Segment Market Overview by Global Region
5.1.1.1 Instruments
5.1.1.2 Reagents & Consumables
5.1.1.3 Software & Services
5.2 Global Polymerase Chain Reaction Market Overview by Application Area
5.2.1 Polymerase Chain Reaction Application Area Market Overview by Global Region
5.2.1.1 Clinical Diagnostics
5.2.1.2 Life Sciences
5.2.1.3 Other Applications
5.3 Global Polymerase Chain Reaction Market Overview by End-Use Sector
5.3.1 Polymerase Chain Reaction End-Use Sector Market Overview by Global Region
5.3.1.1 Academic & Research Institutes
5.3.1.2 Clinical Diagnostics Labs & Hospitals
5.3.1.3 Pharmaceutical & Biotechnology Sectors
5.3.1.4 Other End-Use Sectors

Part B: Regional Market Perspective

Regional Market Overview

1. North America

  • Abbott Laboratories (United States)
  • Abbott Molecular Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • Becton, Dickinson And Company (United States)
  • BD Biosciences, Systems and Reagents Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Raindance Technologies, Inc. (United States)
  • Bruker Corporation (United States)
  • Complete Genomics, Inc. (United States)
  • Danaher Corporation (United States)
  • Beckman Coulter, Inc. (United States)
  • Fluidigm Corporation (United States)
  • Formulatrix, Inc. (United States)
  • Illumina Inc. (United States)
  • Epicentre (United States)
  • Promega Corporation (United States)
  • Roche Diagnostics Corporation (United States)
  • Sigma-Aldrich (United States)
  • Thermo Fisher Scientific, Inc. (United States)

2. Europe

  • Biocartis NV (Belgium)
  • Bioline Reagents Limited (United Kingdom)
  • Dnavision SA (Belgium)
  • Eppendorf AG (Germany)
  • Exiqon A/S (Denmark)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • GE Healthcare Life Sciences (United Kingdom)
  • Merck KGaA (Germany)
  • Qiagen N.V. (The Netherlands)
  • Stilla Technologies (France)

3. Asia-Pacific

  • Hokkaido System Science Co., Ltd. (Japan)
  • Ocimum Biosolutions Ltd. (India)
  • Shimadzu Corporation (Japan)

4. Rest of World

  • HY Laboratories Ltd (Hylabs) (Israel) - A Major Market Player

Part C: Guide to the Industry

1. North America
2. Europe
3. Asia-Pacific
4. Rest of World

Part D: Annexure

Companies Mentioned

  • Abbott Laboratories
  • Abbott Molecular Inc.
  • Agilent Technologies, Inc.
  • BD Biosciences, Systems and Reagents Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis NV
  • Bioline Reagents Limited
  • Bruker Corporation
  • Complete Genomics, Inc.
  • Danaher Corporation
  • Dnavision SA
  • Epicentre
  • Eppendorf AG
  • Exiqon A/S
  • F. Hoffmann-La Roche Ltd
  • Fluidigm Corporation
  • Formulatrix, Inc.
  • GE Healthcare Life Sciences
  • HY Laboratories Ltd (Hylabs)
  • Hokkaido System Science Co., Ltd.
  • Illumina Inc.
  • Merck KGaA
  • Ocimum Biosolutions Ltd.
  • Promega Corporation
  • Qiagen N.V.
  • Raindance Technologies, Inc.
  • Roche Diagnostics Corporation
  • Shimadzu Corporation
  • Sigma-Aldrich
  • Stilla Technologies
  • Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/44czhr/polymerase_chain

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.